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Abstract
Alzheimer’s Disease destroys brain cells causing people to lose their memory,
mental functions and ability to continue daily activities. It is a severe neurological
brain disorder which is not curable, but earlier detection of Alzheimer’s Disease
can help for proper treatment and to prevent brain tissue damage. Detection and
classification of Alzheimer’s Disease (AD) is challenging because sometimes
the signs that distinguish Alzheimer’s Disease MRI data can be found in normal
healthy brain MRI data of older people. Moreover, there are relatively small
amount of dataset available to train the automated Alzheimer’s Disease detection
and classification model. In this paper, we present a novel Alzheimer’s Disease
detection and classification model using brain MRI data analysis. We develop
an ensemble of deep convolutional neural networks and demonstrate superior
performance on the Open Access Series of Imaging Studies (OASIS) dataset.
1 Introduction
There are three major stages in Alzheimer’s Disease - very mild, mild and moderate. Detection
of Alzheimer’s Disease (AD) is still not accurate until a patient reaches moderate AD. But early
detection and classification of AD are critical for proper treatment and preventing brain tissue
damage. Alzheimer’s disease has a certain progressive pattern of brain tissue damage. It shrinks
the hippocampus and cerebral cortex of the brain and enlarges the ventricles [13]. Hippocampus is
the responsible part of the brain for episodic and spatial memory. It also works as a relay structure
between our body and brain. The reduction in hippocampus causes cell loss and damage specifically
to synapses and neuron ends. So neurons cannot communicate anymore via synapses. As a result,
brain regions related to remembering (short term memory), thinking, planning, and judgment are
affected [13]. The degenerated brain cells have low intensity in MRI images [14]. Figure 1 shows
some brain MRI images presenting different AD stage.
(a) (b) (c) (d)
Figure 1: Example of different brain MRI images presenting different AD stage. (a) Nondemented;
(b) very mild dementia ; (c) mild dementia; (d) moderate dementia.
Machine learning studies using neuroimaging data for developing diagnostic tools helped a lot for
automated brain MRI segmentation and classification. Most of them use handcrafted feature genera-
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tion and extraction from the MRI data. After that, the features are fed into machine learning models
such as Support Vector Machine, Logistic regression model, etc. These multi-step architectures are
complex and highly dependent on human experts. Besides, the size of datasets for neuroimaging
studies is small. While image classification datasets used for object detection and classification has
millions of images (for example, ImageNet database [12]), neuroimaging datasets typically have less
than 1000 images. But to develop robust neural networks we need a lot of images. Because of the
scarcity of large image database, it is important to develop models that can learn useful features from
the small dataset. For our research work, we developed an ensemble of deep convolutional neural
networks for Alzheimer’s Disease detection and classification using a small dataset (OASIS database
[7]).
Figure 2: Block diagram of proposed Alzheimer’s disease detection and classification framework.
2 Related Work
Some remarkable research work have been done for automated Alzheimer’s Disease detection and
classification. But majority of them have used ADNI dataset [6]. For example, Aversen et al.[1]
used dimensional reduction and variations methods, Brosch et al.[2] developed a deep belief network
model, Gupta et al.[3] developed a sparse autoencoder model and Payan et al. [8] combined sparse
autoencoders and 3D CNN model for AD detection and classification using ADNI dataset [6].
Amulya et al. [9] used Gray-Level Co-occurrence Matrix (GLCM) method for Alzheimer’s Disease
classification using OASIS database [7]. In our previous work [10], we developed a very deep neural
network inspired by inception-v4 model [11] for Alzheimer’s Disease detection. We will use OASIS
dataset to evaluate our proposed model to check whether the proposed model performs well for small
medical image dataset or not.
3 Proposed Network Architecture
In this section, the proposed Alzheimer’s disease detection and classification framework would
be presented. The proposed model is shown in Figure 2. Our model is an ensemble of three
DenseNet [4] styled model - DenseNet-121, DenseNet-161, and DenseNet-169. Here the numbers
121, 161 and 169 denote the depth of the models. For example, 121 comes from the computation:
5+(6+12+24+16)*2=121, where 5 is (conv,pooling)+3 transition layers+ classification layer. We
multiply with 2 because each dense block has 2 layers (1x1 conv and 3x3 conv). In a DenseNet
[4] styled model, each layer has direct connections to all subsequent layers. So, each layer receives
the feature-maps from all preceding layers. The feature-maps work as global state of the network,
where each layer can add its own feature-map. The global state can be accessed from any part of the
network and how much each layer can contribute to is decided by the growth rate of the network [4].
For each MRI data, we have created patches from three physical planes of imaging: Axial or
horizontal plane, Coronal or frontal plane, and Sagittal or median plane. These patches are feed to
the proposed network as input. We applied transfer learning [5] and the DenseNet-121, DenseNet-
161, and DenseNet-169 models have been pre-trained with ImageNet dataset [12]. Each of the
softmax layer has four different output classes: nondemented, very mild, mild and moderate AD. The
individual models take an MRI image as input and generates its learned representation. Based on this
feature representation, the input MRI image is classified to any of the four output classes. To measure
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the loss of each of these models, we have used cross entropy. The Softmax layer takes the learned
representation, fi and interprets it to the output class. A probability score, pi is also assigned for the
output class. If we define the number of Alzheimer’s disease stages as m, then we get
pi =
exp(f i)∑
i exp(f i)
, i = 1, ...,m
and
L = −
∑
i
tilog(pi),
where L is the loss of cross entropy of the network. Back propagation is used to calculate the gradients
of the network. If the ground truth of an MRI image is denoted as ti, then,
∂L
∂fi
= pi − ti
The output classification label of the three individual model are ensembled together using voting
technique. Each classifier “votes” for a particular class, and the class with the majority votes would
be assigned as the label for the input MRI data. Since the dataset is small, 5-fold cross validation
is performed on the dataset. For each fold, We have used 70% as training data, 10% as validation
data and 20% as test data. The individual models are optimized with the Stochastic Gradient Descent
(SGD) algorithm and early-stopping is used for regularization.
4 Experiments
4.1 Dataset
Figure 3: Sample images from OASIS dataset [7].
OASIS dataset [7] have 416 subjects aged 18 to 96, and for each of them, 3 or 4 T1-weighted MRI
scans are available. 100 of the patients having age over 60 are included in the dataset with very mild
to moderate AD. Figure 3 shows some sample brain MRI images from OASIS dataset. Since the
dataset is small, 5-fold cross validation is performed on the dataset.
Table 1: Performance of the DenseNet-121 model on the OASIS dataset [7]
Class precision recall f1–score support
non-demented 0.99 0.99 0.99 73
very mild 0.75 0.50 0.60 6
mild 0.62 0.71 0.67 7
moderate 0.33 0.50 0.40 2
avg/total 0.93 0.92 0.92 88
Table 2: Performance of the DenseNet-161 model on the OASIS dataset [7]
Class precision recall f1–score support
non-demented 0.88 0.95 0.91 73
very mild 0.00 0.00 0.00 6
mild 0.25 0.29 0.27 7
moderate 0.00 0.00 0.00 2
avg/total 0.75 0.81 0.78 88
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Table 3: Performance of the DenseNet-169 model on the OASIS dataset [7]
Class precision recall f1–score support
non-demented 0.99 0.96 0.97 73
very mild 0.50 0.33 0.40 6
mild 0.45 0.71 0.56 7
moderate 0.50 0.50 0.50 2
avg/total 0.90 0.89 0.89 88
Table 4: Performance of the proposed ensembled model on the OASIS dataset [7]
Class precision recall f1–score support
non-demented 0.97 1.00 0.99 73
very mild 1.00 0.33 0.50 6
mild 0.67 0.86 0.75 7
moderate 0.50 0.50 0.50 2
avg/total 0.94 0.93 0.92 88
4.2 Results
Table 1, Table 2, and Table 3 shows the individual performance of DenseNet-121, DenseNet-161, and
DenseNet-169 model respectively. Table 4 shows the performance of our proposed ensembled model
on the OASIS dataset [7] which is better than each of the individual DenseNet-121, DenseNet-161,
and DenseNet-169 model. The accuracy of the proposed model is 93.18% with 93% precision, 92%
recall and 92% f1–score. The performance comparison of classification results of the proposed
ensembled model and the previous state–of–the–art is presented in Table 5. As we can see, proposed
ensembled model achieves encouraging performance and outperforms the previous state-of the art.
The reason behind the success of the proposed model with such small dataset is due to using the class
weights in the training process.
5 Conclusion
We have provided an one step analysis for the 3D brain MRI data for Alzheimer’s Disease detection
and classification. The distinction between very mild and mild class would help to identify the
current stage for early stage Alzheimer’s Disease patient. Our system could be used for clinical
decision making process to detect and classify different stages of Alzheimer’s Disease. Though the
proposed model has only been tested on Alzheimer’s Disease data, we believe it can be used for other
classification problems in the medical domain. Moreover, the proposed ensembled approach can be
used for applying CNN into other domains with limited dataset.
Table 5: Comparison of classification results on the OASIS dataset [7]
Methods accuracy precision recall f1–score
GLCM[9] 75.71% 63.84% 100% 77.92%
Proposed ensembled model 93.18% 94% 93% 92%
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